FORMULATION AND IN VITRO EVALUATION OF ORO DISPERSIBLE TABLETS OF LORAZEPAM
Journal Title: Indo American Journal of Pharmaceutical Sciences - Year 2018, Vol 5, Issue 5
Abstract
The present investigation was done on lorazepam orodispersible tablets using super disintegrants. The prepared powder blend for all formulations was found to be within limits. Tablets were compressed using rotary tablet compression machine. Post compression studies like weight variation, hardness, thickness, friability, drug content, in vitro disintegration time were carried out which were found to be within limits. In vitro drug release studies revealed that Among all formulations F4 formulation were shown maximum drug release(99.99%) at 45 min. Among these three formulations F4 was considered as optimised formulation due to 2 mg of croscarmellose sodium. Key words: Lorazepam, Super disintegrants, Orodispersble tablets.
Authors and Affiliations
Keywords
Related Articles
- EP ID EP287808
- DOI -
- Views 252
- Downloads 0
ALZHEIMER’S – CURRENT STRATEGIES FOR ITS DIAGNOSIS AND TREATMENT
Alzheimer’s disease is the most prevailing type of dementia worldwide with pathological hallmarks as neurofibrillary tangles and amyloid β plaque. A large number of research and studies are undergoing to determine the ex...
ESTIMATION OF DIFFERENT EXTRACTS OF AMARANTHUS VIRIDIS L FOR INVITRO ANTIOXIDANT ACTIVITY
Back ground: The plant Amaranthus viridis L (Amaranthaceous) is commonly known as “Never-fading flower” and “Slender amaranth” in Greek and English respectively. These plants have been traditionally used as antiulcer, an...
DESCRIPTIVE RESEARCH ANALYSIS OF THE SHUNT BLOCKAGE IN VENTRICULO-PERITONEAL (VP) SHUNTS FOR HYDROCEPHALOUS WITH REFERENCE TO AGE, SEX AND INTERVAL OF REPLACEMENT OF VP SHUNT TO REVISION AT MAYO HOSPITAL, LAHORE
Background: In the established hydrocephalous a common modality of the treatment is ventriculoperitoneal shunt. Our research was aimed at the determination of the age and sex distribution, cause and site and post-operati...
A VALIDATED STABILITY-INDICATING AND LC-MS COMPATIBLE METHOD FOR THE DETERMINATION OF RELATED SUBSTANCES AND ASSAY OF MONTELUKAST SODIUM AND LEVOCETIRIZINE HCL BY U-HPLC IN TABLET DOSAGE FORM
A novel gradient reverse-phase ultra-high performance liquid chromatography (U-HPLC) method has been developed and validated for determination of related substances and assay of Montelukast sodium and Levocetirizine HCl...
METHOD DEVELOPMENT AND VALIDATION OF UV SPECTROPHOTOMETRIC METHODS FOR THE ESTIMATION OF DARUNAVIR IN BULK AND ITS PHARMACEUTICAL DOSAGE FORM
Two simple, precise and economical UV Spectrophotometric methods have been developed for the estimation of Darunavir ethanolate (DRV) in bulk and its pharmaceutical dosage form. Two methods were developed based on measur...